Gu�a Navide�a

December 2004
Vistazo;12/2/2004, Issue 895, p24
No abstract available.


Related Articles

  • MSLs deployed in launch of Navidea diagnostic agent. M. I. // Medical Marketing & Media;Jun2013, Vol. 48 Issue 6, p14 

    The article reports on the launch of diagnostic cancer agent Lymphoseek by Navidea Biopharmaceuticals.

  • World literature in review: China. Yeh, Michelle // World Literature Today;Summer92, Vol. 66 Issue 3, p577 

    Reviews the book `The Women Trilogy,' by Bai Fengxi and translated by Gua Yuehua.

  • Dam Good Sweet.  // Restaurant Hospitality;Dec2009, Vol. 93 Issue 12, p24 

    The article reviews the book "Dam Good Sweet," by David Guas.

  • Navidea snares NDA for Lymphoseek.  // Medical Device Daily;3/20/2013, Vol. 17 Issue 54, Special section p1 

    The article reports on the U.S. Food and Drugs administration approval received by Navidea Biopharmaceuticals for Lymposeek radiotracer.

  • CHEF CÉLÈBRE. Pipkin, Whitney // Virginia Living;Aug2014, Vol. 12 Issue 5, p15 

    The article features celebrity chef David Guas, owner of the Bayou Bakery, Coffee Bar and Eatery located in Arlington, Virginia. An overview of chef Guas' personal and career background is provided. Information on the different menus that chef Guas knew, his passion for the origins of food, and...

  • MAGNIFICENT MELONS: welcome to the family cucurbitaceae! Redmon, Laurel // Oriental Medicine Journal;Aug2006, Vol. 14 Issue 5, p26 

    This article describes several fruits that belong to the Cucurbitaceae family. It includes the American pumpkin, cantaloupe and honeydew melon, loofa/si gua luo, and summer squash. Also included are trichosanthes/gua luo, watermelon, winter melon/dong gua ren, and winter squash. Medicinal...

  • Neoprobe Corp Becomes Navidea Biopharmaceuticals.  // Biomedical Market Newsletter;1/7/2012, Vol. 21, p1 

    The article offers information on the change of the name of Neoprobe Corp. to Navidea Biopharmaceuticals Inc. to reflect the company's dedication to navigating ideas for the development of novel products. Navidea Biopharmaceuticals focuses on the development and commercialization of diagnostics...

  • Navidea Biopharmaceuticals Enters into Option Agreement to License Parkinson's Disease Imaging Agent.  // Biomedical Market Newsletter;1/28/2012, Vol. 21, p1 

    The article offers information on an option agreement between Navidea Biopharmaceuticals Inc. and Alseres Pharmaceuticals Inc. to the License Iodine-123 radiolabeled imaging agent for diagnosis of the Parkinson's disease and movement disorders. The exclusive rights to perform final due diligence...

  • Lymphoseek data hit the literature.  // Medical Device Daily;3/27/2013, Vol. 17 Issue 59, Special section p1 

    This article reports that the data behind the trials of Navidea Biopharmaceuticals' new cancer tracer drug Lymphoseek will appear on the online edition of the "Annals of Surgical Oncology."

  • Financings Roundup.  // BioWorld Today;12/21/2012, Vol. 23 Issue 247, p7 

    The article reports on the acquisition by Platinum-Montaur Life Sciences LLC of shares of common stock in Navidea Biopharmaceuticals Inc. by exercising Series W warrants.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics